Established brands represent the majority of portfolios across pharma’s global affiliates that are often neglected, with revenue and profit growth untapped. With pharma due to witness a complete transformation as exclusivity rights to 569 medications valued at $278 billion are set to expire by 2029/2030, the time to prepare is now.

Join industry experts to learn more about the “five-step approach” that will allow you to take a deep dive into your established brands. This includes a look at: brand portfolio, brand strategy, brand path, tailored solutions, and the specific capabilities needed. Gain a clear and confident approach for established brand optimization and unlock your brand potential.

• The changing market landscape and its relevance for Established Brands portfolio
• How to select the best strategy for your brand to build the most value
• Key strategies and solutions available to support and manage the Established Brands portfolio
• Recent real-life examples from leading industry organizations
• And more